| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $99.1M | -0.2% |
| SG&A Expense | $23.0M | -18.8% |
| Operating Income | -$122.1M | +4.3% |
| Interest Expense | $36K | +800.0% |
| Pre-tax Income | -$116.8M | +0.3% |
| Income Tax | $0 | — |
| Net Income | -$116.8M | +0.3% |
| EPS (Basic) | -$16.95 | -1174.4% |
| EPS (Diluted) | -$16.95 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.9M | -31.1% |
| Current Assets | $160.9M | -10.7% |
| Total Assets | $192.4M | -12.7% |
| Current Liabilities | $21.5M | +11.0% |
| Total Liabilities | $33.1M | -1.4% |
| Stockholders' Equity | $159.2M | -14.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$95.2M | -3.1% |
| Capital Expenditures | $1.7M | +55.5% |
| Investing Cash Flow | $2.4M | +102.0% |
| Financing Cash Flow | $75.2M | -32.4% |
| Free Cash Flow | -$97.0M | -3.7% |
| -1174.4% |